LHH Corporation

LHH Corporation, doing business as Lenox Hill Hospital, is a New York-based tax-exempt hospital and non-profit organization that receives federal grant funding as a sub-recipient under the Substance Abuse and Mental Health Services Administration (SAMHSA), primarily to support early intervention and specialized behavioral health programs. The entity does not hold prime federal contracts or IDVs; all federal funding activity flows through sub-grant awards administered by the New York State Office of Mental Health.

Lenox Hill's federal grant footprint centers on the On-Track New York program, a SAMHSA-funded initiative that provides specialized, team-based care for young people experiencing their first episodes of psychosis. The hospital serves as a sub-recipient under multiple tranches of this grant, with documented sub-award activity dating to January 2023 and continuing through April 2026. Recent sub-grant awards include funding received in April 2026, February 2025, and July 2023 (multiple tranches covering On-Track New York and First Episode Psychosis components). Combined obligated dollars across all federal awards total $2.2 million against $1.5 million in combined potential value, reflecting reimbursement-based federal grant accounting where actual spending can exceed initial estimates.

The hospital's federal customer concentration is narrow and singular: all named federal awards flow from the Department of Health and Human Services SAMHSA. The vendor_award_portfolio block reports only two distinct customer agencies served, with SAMHSA accounting for seven awards visible in the top-customers summary. The source's coverage percentages (16% for award count, 0% for potential value) indicate that the award-portfolio snapshot captures a small slice of the vendor's overall operations; the remaining 84% of the forty-three total awards and the majority of obligated dollars likely represent direct federal prime grants or other funding sources not enumerated in the sub-grant slice provided. Across the full forty-three-award history spanning 2005 to 2026, the preponderance of categorization reflects health and welfare funds (32 awards) and health R&D services (31 awards) under NAICS and PSC coding.

Activity is episodic rather than continuous, with clusters in 2008 and 2023 and recent individual awards in 2025 and 2026. The hospital does not compete for or hold prime contracts and is not positioned as a teaming prime for contractors seeking behavioral health or research sub-recipients. Its federal footprint is purely grant-based, routed through state intermediaries, and concentrated on specialized early-intervention psychiatric care delivery.